Acupuncture for the Alleviation of Hot Flashes in Men Treated With Androgen Ablation Therapy


      Hot flashes are common side effect due to androgen ablation therapy (AAT). The utility of acupuncture for hot flashes in men has not been thoroughly studied. We prospectively studied the effect of acupuncture in men with hot flashes.

      Methods and Materials

      The study was approved by internal review board. Seventeen men with hot flashes and history of AAT for prostate cancer were enrolled. Three men declined participation before receiving any treatment. A hot flash score (HFS) was used to measure daily hot flashes. The composite daily score was calculated as the product of frequency × severity. The baseline daily scores were compared with scores taken at 2 and 6 weeks and at 8-month average follow-up.


      No side effects were encountered during, immediately after treatment, or at 8 months. The mean initial HFS was 28.3; it dropped to 10.3 (p = 0.0001) at 2 weeks posttreatment, 7.5 (p = 0.0001) at 6 weeks, and 7.0 (p = 0.001) at 8 months. Clinical improvement for each patient is defined as the percent decrease in the mean HFS at each time point. The mean improvement at Weeks 2 and 6 was 68.4% (mean HFS decreased from 37.409 to 11.836, p = 0.001) and 89.2% (mean HFS decreased from 37.409 to 4.05, p = 0.0078) respectively. The improvement at 8 months was 80.3% (mean HFS decreased from 37.409 to 7.385, p = 0.002).


      Acupuncture provides excellent control of hot flashes in men with a history of AAT. The absence of side effects and the durable response at 8 months are likely to be appealing to patients. Prospective randomized study is warranted to further evaluate this modality against medical therapy.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Purchase one-time access:

      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Casper R.F.
        • Yen S.S.C.
        Neuroendocrinology of menopausal flushes: An hypothesis of flush mechanism.
        Clin Endocrinol. 1985; 22: 293-312
        • Kronenberg F.
        Menopausal hot flashes: Randomness or rhythmicity.
        Chaos. 1991; 1: 271-278
        • Spetz A.C.
        • Zetterlund E.L.
        • Varenhorst E.
        • et al.
        Incidence and management of hot flashes in prostate cancer.
        J Support Oncol. 2003; 1: 263-266
        • Loprinzi C.L.
        • Sloan J.
        • Stearns V.
        • et al.
        Newer antidepressants and gabapentin for hot flashes: An individual patient pooled analysis.
        J Clin Oncol. 2009; 16: 883-887
        • Quella S.K.
        • Loprinzi C.L.
        • Sloan J.A.
        • et al.
        Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
        J Clin Oncol. 1998; 16: 2377-2381
        • Loprinzi C.
        • Dueck A.C.
        • Khoyratty B.S.
        • et al.
        A Phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men.
        Ann Oncol. 2009; 20: 542-549
        • Nelson H.
        • Vesco K.
        • Haney E.
        • et al.
        Nonhormonal therapies for menopausal hot flashes: Systematic review and meta-analysis.
        JAMA. 2006; 295: 2057-2071
        • Lin J.G.
        • Chen W.L.
        Acupuncture analgesia: A review of its mechanisms of actions.
        Am J Chin Med. 2008; 36: 635-645
        • Han S.J.
        Acupuncture and endorphins.
        Neurosci Lett. 2004; 361: 258
        • Shanafelt T.
        • Barton D.
        • Adjei A.
        • et al.
        Pathophysiology and treatment of hot flashes.
        Mayo Clinic Proc. 2002; 77: 1207-1218
        • Berendsen H.
        The role of serotonin in hot flushes.
        Maturitas. 2000; 36: 155-164
        • Frisk J.
        • Spetz A.C.
        • Hjertberg H.
        • et al.
        Two modes of acupuncture as a treatment for hot flushes in men with prostate cancer—a prospective multicenter study with long term follow-up.
        Eur Urol. 2009; 55: 156-163
        • Hammar M.
        • Frisk J.
        • Grimas O.
        • et al.
        Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: A pilot study.
        J Urol. 1999; 161: 853-856
        • Hayes M.
        • Katovic N.M.
        • Donovan D.
        • et al.
        Acupuncture for hot flashes in prostate cancer patients.
        J Clin Oncol. 2005; 23 ([Abstract]): 8160
        • Oken M.M.
        • Creech R.H.
        • Tormey D.C.
        • et al.
        Toxicity and response criteria of the eastern cooperative oncology group.
        Am J Clin Oncol. 1982; 5: 649-655
        • STATA Corp
        Stata Statistical Software. Release 10.
        StataCorp, College Station, TX2007
        • Sloan J.A.
        • Loprinzi C.L.
        • Novotny P.J.
        • et al.
        Methodologic lessons learned from hot flash studies.
        J Clin Oncol. 2001; 19: 4280-4290
        • Higano C.S.
        Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity.
        Urology. 2003; 61: 32
        • Loprinzi C.L.
        • Barton D.L.
        • Sloan J.A.
        • et al.
        Mayo Clinic and North Central Cancer Treatment Group hot flash studies: A 20-year experience.
        Menopause. 2008; 15: 655-660
        • Loprinzi C.L.
        • Barton D.L.
        • Carpenter L.A.
        • et al.
        Pilot evaluation of paroxetine for treating hot flashes in men.
        Mayo Clinic. 2004; 79: 1247-1251


      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.